Detalles de la búsqueda
1.
Bcl1 polymorphism of the glucocorticoid receptor gene and treatment response to milnacipran and fluvoxamine in Japanese patients with depression.
Neuropsychobiology
; 70(3): 173-80, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25358426
2.
Predictors of response to electroconvulsive therapy obtained using the three-factor structure of the Montgomery and Asberg Depression Rating Scale for treatment-resistant depressed patients.
J ECT
; 26(2): 87-90, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19710622
3.
[Prediction of antidepressant response to milnacipran and fluvoxamine using pharmacogenetical methods].
Nihon Shinkei Seishin Yakurigaku Zasshi
; 30(2): 71-6, 2010 Apr.
Artículo
en Japonés
| MEDLINE | ID: mdl-20491280
4.
Augmentation with olanzapine in TCA-refractory depression with melancholic features: a consecutive case series.
Hum Psychopharmacol
; 23(3): 217-20, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18172909
5.
Influence of the tyrosine hydroxylase val81met polymorphism and catechol-O-methyltransferase val158met polymorphism on the antidepressant effect of milnacipran.
Hum Psychopharmacol
; 23(2): 121-8, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18023073
6.
Predictors of antidepressant response to fluvoxamine obtained using the three-factor structures of the Montgomery and Asberg Depression Rating Scale for major depressive disorders in Japanese patients.
Psychiatry Clin Neurosci
; 62(3): 301-6, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18588590
7.
No predictors of antidepressant patient response to milnacipran were obtained using the three-factor structures of the Montgomery and Asberg Depression Rating Scale in Japanese patients with major depressive disorders.
Psychiatry Clin Neurosci
; 62(2): 197-202, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18412843
8.
The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine.
J Psychopharmacol
; 21(6): 650-6, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17092970
9.
Probable aripiprazole-induced tardive writer's cramp.
J Neuropsychiatry Clin Neurosci
; 24(3): E44, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23037681
10.
Association between serotonin transporter polymorphisms (5-HTTLPR) and the MADRS Dysphoria, Retardation, and Vegetative Subscale scores in the treatment of depression.
Neuropsychiatr Dis Treat
; 13: 1463-1469, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28652746
11.
Switching to risperidone after unsuccessful treatment of olanzapine in the first-episode schizophrenia: an open trial.
Prog Neuropsychopharmacol Biol Psychiatry
; 30(6): 1067-72, 2006 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-16759777
12.
Response rate obtained using milnacipran depending on the severity of depression in the treatment of major depressive patients.
Clin Neuropharmacol
; 29(1): 6-9, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16518126
13.
Remarkable effect of milnacipran, a serotonin-noradrenalin reuptake inhibitor (SNRI), on depressive symptoms in patients with Parkinson's disease who have insufficient response to selective serotonin reuptake inhibitors (SSRIs): two case reports.
Prog Neuropsychopharmacol Biol Psychiatry
; 29(2): 351-3, 2005 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-15694247
14.
Remarkable effect of selegiline (L-deprenyl), a selective monoamine oxidase type-B inhibitor, in a patient with severe refractory depression: a case report.
Clin Neuropharmacol
; 28(4): 191-2, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-16062100
15.
Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms.
Am J Psychiatry
; 161(9): 1575-80, 2004 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-15337646
16.
Tardive dystonia and genetic polymorphisms of cytochrome P4502D6 and dopamine D2 and D3 receptors: a preliminary finding.
Am J Med Genet
; 114(6): 693-5, 2002 Aug 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-12210290
17.
Relationship between clinical effects of fluvoxamine and the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients.
Psychopharmacology (Berl)
; 167(4): 443-8, 2003 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12682708
18.
Quetiapine treatment of psychotic symptoms and aggressive behavior in patients with dementia with Lewy bodies: a case series.
Prog Neuropsychopharmacol Biol Psychiatry
; 27(3): 549-53, 2003 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-12691793
19.
Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients.
Prog Neuropsychopharmacol Biol Psychiatry
; 26(2): 383-6, 2002 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-11817517
20.
Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder.
Prog Neuropsychopharmacol Biol Psychiatry
; 26(7-8): 1279-83, 2002 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-12502014